Literature DB >> 20979941

Relationship between carnosinase gene CNDP1 leucine repeat polymorphism and the clinical outcome of Chinese PD patients.

P Y-K Poon1, C-C Szeto, B C-H Kwan, K-M Chow, P K-T Li.   

Abstract

BACKGROUND: pre-clinical studies showed that carnosine may have a beneficial cardiovascular effect. We studied the effect of tri-nucleotide repeat (CTGs) polymorphisms in exon 2 of the CNDP1 gene, which codes for carnosinase and is responsible for the degradation of carnosine, on the clinical outcome of Chinese peritoneal dialysis (PD) patients.
METHODS: we studied 442 PD subjects. Genotyping was done by direct sequencing of genomic DNA. Patients were followed for 43.5 ± 16.2 months.
RESULTS: the prevalence of 6-6, 5-6, 5-5 and 4-6 CTGs genotypes was 80.3%, 18.6%, 0.9% and 0.2%, respectively. A total of 270 patients (61.1%) developed the primary composite end point during follow-up. The 5-year event-free survival of the 6-6 CTGs and non 6-6 group was 37.1% and 21.3%, respectively (log rank test, p = 0.3).
CONCLUSION: the CTGs polymorphism of the CNDP1 gene does not affect survival of Chinese PD subjects. The role of carnosine and CNDP1 gene polymorphism in the pathogenesis of cardiovascular disease requires further study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20979941     DOI: 10.5414/cnp74343

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

Review 1.  Genetic Polymorphisms and Peritoneal Membrane Function.

Authors:  Imad Siddique; K Scott Brimble; Louise Walkin; Angela Summers; Paul Brenchley; Sarah Herrick; Peter J Margetts
Journal:  Perit Dial Int       Date:  2014-11-13       Impact factor: 1.756

2.  Association of variants in the carnosine peptidase 1 gene (CNDP1) with diabetic nephropathy in American Indians.

Authors:  Harini A Chakkera; Robert L Hanson; Sayuko Kobes; Meredith P Millis; Robert G Nelson; William C Knowler; Johanna K Distefano
Journal:  Mol Genet Metab       Date:  2011-02-19       Impact factor: 4.797

3.  The CNDP1 (CTG)5 Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration.

Authors:  Thomas Albrecht; Shiqi Zhang; Jana D Braun; Li Xia; Angelica Rodriquez; Jiedong Qiu; Verena Peters; Claus P Schmitt; Jacob van den Born; Stephan J L Bakker; Alexander Lammert; Hannes Köppel; Peter Schnuelle; Bernhard K Krämer; Benito A Yard; Sibylle J Hauske
Journal:  J Diabetes Res       Date:  2017-05-03       Impact factor: 4.011

4.  CNDP1, NOS3, and MnSOD Polymorphisms as Risk Factors for Diabetic Nephropathy among Type 2 Diabetic Patients in Malaysia.

Authors:  Mohd Jokha Yahya; Patimah Binti Ismail; Norshariza Binti Nordin; Abdah Binti Md Akim; Wan Shaariah Binti Md Yusuf; Noor Lita Binti Adam; Nurul Fasihah Zulkifli
Journal:  J Nutr Metab       Date:  2019-01-03

5.  Protocol to assess the efficacy of carnosine supplementation in mitigating the adverse cardiovascular responses to particulate matter (PM) exposure: the Nucleophilic Defense Against PM Toxicity (NEAT) trial.

Authors:  Timothy E O'Toole; Alok A Amraotkar; Andrew P DeFilippis; Shesh N Rai; Rachel J Keith; Shahid P Baba; Pawel Lorkiewicz; Catherine E Crandell; Gina L Pariser; Christopher J Wingard; C Arden Pope Iii; Aruni Bhatnagar
Journal:  BMJ Open       Date:  2020-12-28       Impact factor: 2.692

6.  The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes.

Authors:  Mahiro Kurashige; Minako Imamura; Shin-Ichi Araki; Daisuke Suzuki; Tetsuya Babazono; Takashi Uzu; Tomoya Umezono; Masao Toyoda; Koichi Kawai; Masahito Imanishi; Kazushige Hanaoka; Hiroshi Maegawa; Yasuko Uchigata; Tatsuo Hosoya; Shiro Maeda
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

7.  Genotype Distribution of CNDP1 Polymorphisms in the Healthy Chinese Han Population: Association with HbA1c and Fasting Blood Glucose.

Authors:  Shiqi Zhang; Juan Xu; Di Cui; Shujuan Jiang; Xin Xu; Yi Zhang; Dongchun Zhu; Li Xia; Benito Yard; Yonggui Wu; Qiu Zhang
Journal:  J Diabetes Res       Date:  2020-07-18       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.